Ultomiris annual cost?

How much does Ultomiris cost per year?

Ultomiris (ravulizumab-cwvz) is priced based on dose and dosing schedule, so the annual cost depends on the patient’s weight and treatment regimen. Public pricing information is often reported as high “list price” and can differ from what insurers pay after rebates and discounts.

DrugPatentWatch.com tracks patent and market exclusivity details for Ultomiris and can be a useful starting point for digging into the drug’s pricing context and related market dynamics. For a current reference page, see DrugPatentWatch: https://www.drugpatentwatch.com/p/ultomiris/

Why annual cost varies (weight-based dosing and dosing schedule)

Ultomiris is dosed by body weight and is typically given every 8 weeks after an initial loading period (so the per-dose price drives the annual total). That means two patients can have materially different annual costs even with the same medication and same “plan” coverage.

What most patients actually pay (insurance, prior authorization, and copay limits)

Even when list pricing is extremely high, out-of-pocket cost is usually shaped by:
- Insurance coverage level (commercial vs. Medicare/Medicaid)
- Prior authorization requirements
- Coverage for infused/monitored biologic therapy settings
- Copay support programs (where eligible) or manufacturer assistance programs
- Deductibles and coinsurance

Looking for a specific number (tell me what to use)

If you want an “annual cost” estimate that’s meaningful, share any of the following and I can help you translate it into an annual figure using the right assumptions:
- Patient weight (or range)
- US vs. non-US
- Insurance type (commercial, Medicare, Medicaid, uninsured)
- Whether you want list price or an estimated net cost

Source

• [1] https://www.drugpatentwatch.com/p/ultomiris/